{"url_path":"/sec/lfcr/8-k/2026-03-16/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-03-16","source_url":"https://www.sec.gov/Archives/edgar/data/1005286/0001005286-26-000007-index.html","accession_number":"0001005286-26-000007","cik":"0001005286","ticker":"LFCR","issuer_name":"LIFECORE BIOMEDICAL, INC. \\DE\\","edgar_url":"https://www.sec.gov/Archives/edgar/data/1005286/0001005286-26-000007-index.html","primary_entity_key":"0001005286","primary_entity_name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"word_count":96,"has_tables":true,"body_markdown":"Item 9.01    Financial Statements and Exhibits.\n\n(d) Exhibits\n\nExhibit No.Description\n\n99.1\n[Press Release issued March 16, 2026 by Lifecore Biomedical, Inc.](lfcr-ty25q4xex991earningsr.htm)\n\n99.2\n[Lifecore Biomedical Investor Presentation dated March 16, 2026](ex992_lfcrpresentation.htm)\n\n104Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.\n\nSIGNATURE\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nDate: March 16, 2026\n\nLIFECORE BIOMEDICAL, INC.\n\nBy:/s/ Ryan D. Lake\n\nRyan D. Lake\n\nChief Financial Officer"}